World Journal of Pediatrics

, Volume 5, Issue 1, pp 23–30

Metabolic syndrome in fifth grade children with acanthosis nigricans: results from the CARDIAC project

  • Christa L. Ice
  • Emily Murphy
  • Valerie Evans Minor
  • William A. Neal
Original Article

Abstract

Background

A number of cardiovascular disease (CVD) risk factors have been linked to obesity and associated negative health outcomes in children. However, no consistent definition of metabolic syndrome exists for children. In addition, research is needed to systematically examine the prevalence of metabolic syndrome in high-risk children, including those with insulin resistance. This study explores several definitions of metabolic syndrome and determines the prevalence of metabolic syndrome in a large sample of children with acanthosis nigricans (AN).

Methods

The study used results from a large-scale screening of fifth-grade students in West Virginia to explore the prevalence of metabolic syndrome among 676 male and female participants who had mild to severe AN.

Results

In this high-risk sample of students who had AN, 49% met the criteria, i.e., three risk factors including insulin resistance, high body-mass index, and elevated blood pressure or dyslipidemia, when tested for metabolic syndrome. Children with AN who were classified as obese or morbidly obese were at significantly increased odds of having metabolic syndrome.

Conclusions

Results are discussed in terms of systematically defining metabolic syndrome for high-risk children, as well as public health and clinical interventions targeting children who are overweight or obese. The presence of AN and morbid obesity might be easily observed markers for metabolic syndrome.

Key words

acanthosis nigricans children metabolic syndrome obesity risk factors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002;288:1723–1727.PubMedCrossRefGoogle Scholar
  2. 2.
    Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 1998;101:497–504.PubMedGoogle Scholar
  3. 3.
    Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295:1549–1555.PubMedCrossRefGoogle Scholar
  4. 4.
    Berenson GS, Srinivasan SR, Wattigney WA, Harsha DW. Obesity and cardiovascular risk in children. Ann N Y Acad Sci 1993;699:93–103.PubMedCrossRefGoogle Scholar
  5. 5.
    Williams DP, Going SB, Lohman TG, Harsha DW, Srinivasan SR, Webber LS, et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health 1992;82:358–363.PubMedCrossRefGoogle Scholar
  6. 6.
    Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999;103:1175–1182.PubMedCrossRefGoogle Scholar
  7. 7.
    Engeland A, Bjorge T, Sogaard AJ, Tverdal A. Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol 2003;157:517–523.PubMedCrossRefGoogle Scholar
  8. 8.
    Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650–1656.PubMedCrossRefGoogle Scholar
  9. 9.
    Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 2005;149:33–45.PubMedCrossRefGoogle Scholar
  10. 10.
    Steinberger J. Diagnosis of the metabolic syndrome in children. Curr Opin Lipidol 2003;14:555–559.PubMedCrossRefGoogle Scholar
  11. 11.
    Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403–414.PubMedCrossRefGoogle Scholar
  12. 12.
    Hud JA Jr, Cohen JB, Wagner JM, Cruz PD Jr. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 1992;128:941–944.PubMedCrossRefGoogle Scholar
  13. 13.
    Sinha S, Schwartz RA. Juvenile acanthosis nigricans. J Am Acad Dermatol 2007;57:502–508.PubMedCrossRefGoogle Scholar
  14. 14.
    Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med 1989;87: 269–272.PubMedCrossRefGoogle Scholar
  15. 15.
    Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr 2008;152:160–164.PubMedCrossRefGoogle Scholar
  16. 16.
    Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep 2004;4:53–62.PubMedCrossRefGoogle Scholar
  17. 17.
    Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575–581.PubMedCrossRefGoogle Scholar
  18. 18.
    Chen W, Srinivasan SR, Li S, Xu J, Berenson GS. Clustering of long-term trends in metabolic syndrome variables from childhood to adulthood in Blacks and Whites: the Bogalusa Heart Study. Am J Epidemiol 2007;166:527–533.PubMedCrossRefGoogle Scholar
  19. 19.
    Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 2007;120:340–345.PubMedCrossRefGoogle Scholar
  20. 20.
    Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 2008;152:201–206.PubMedCrossRefGoogle Scholar
  21. 21.
    Rappaport EB. Identifying and evaluating the metabolic syndrome in children and adolescents. Ethn Dis 2007;17: S4-1–S4-6.Google Scholar
  22. 22.
    Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362–2374.PubMedCrossRefGoogle Scholar
  23. 23.
    Calcaterra V, Klersy C, Muratori T, Telli S, Caramagna C, Scaglia F, et al. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf) 2008;68:868–872.CrossRefGoogle Scholar
  24. 24.
    Moore JB, Davis CL, Baxter SD, Lewis RD, Yin Z. Physical activity, metabolic syndrome, and overweight in rural youth. J Rural Health 2008;24:136–142.PubMedCrossRefGoogle Scholar
  25. 25.
    Huang TT, Ball GD, Franks PW. Metabolic syndrome in youth: current issues and challenges. Appl Physiol Nutr Metab 2007;32:13–22.PubMedCrossRefGoogle Scholar
  26. 26.
    Kong AS, Williams RL, Smith M, Sussman AL, Skipper B, Hsi AC, et al. Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices. Ann Fam Med 2007;5:202–208.PubMedCrossRefGoogle Scholar
  27. 27.
    Brickman WJ, Binns HJ, Jovanovic BD, Kolesky S, Mancini AJ, Metzger BE. Acanthosis nigricans: a common finding in overweight youth. Pediatr Dermatol 2007;24:601–606.PubMedCrossRefGoogle Scholar
  28. 28.
    Nguyen TT, Keil MF, Russell DL, Pathomvanich A, Uwaifo GI, Sebring NG, et al. Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight African American and white children. J Pediatr 2001;138: 474–480.PubMedCrossRefGoogle Scholar
  29. 29.
    Katz AS, Goff DC, Feldman SR. Acanthosis nigricans in obese patients: presentations and implications for prevention of atherosclerotic vascular disease. Dermatol Online J 2000;6:1.PubMedGoogle Scholar
  30. 30.
    Guran T, Turan S, Akcay T, Bereket A. Significance of acanthosis nigricans in childhood obesity. J Paediatr Child Health 2008;44:338–341.PubMedCrossRefGoogle Scholar
  31. 31.
    Stoddart ML, Blevins KS, Lee ET, Wang W, Blackett PR. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study. Diabetes Care 2002;25:1009–1014.PubMedCrossRefGoogle Scholar
  32. 32.
    Kobaissi HA, Weigensberg MJ, Ball GD, Cruz ML, Shaibi GQ, Goran MI. Relation between acanthosis nigricans and insulin sensitivity in overweight Hispanic children at risk for type 2 diabetes. Diabetes Care 2004;27:1412–1416.PubMedCrossRefGoogle Scholar
  33. 33.
    Shalitin S, Abrahami M, Lilos P, Phillip M. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int J Obes (Lond) 2005;29:571–578.CrossRefGoogle Scholar
  34. 34.
    Hirschler V, Aranda C, Oneto A, Gonzalez C, Jadzinsky M. Is acanthosis nigricans a marker of insulin resistance in obese children? Diabetes Care 2002;25:2353.PubMedCrossRefGoogle Scholar
  35. 35.
    Muratova VN, Demerath EW, Spangler E, Ogershok P, Elliott E, Minor VE, et al. The relation of obesity to cardiovascular risk factors among children: the CARDIAC project. W V Med J 2002;98:263–267.PubMedGoogle Scholar
  36. 36.
    Demerath E, Muratova V, Spangler E, Li J, Minor VE, Neal WA. School-based obesity screening in rural Appalachia. Prev Med 2003;37:553–560.PubMedCrossRefGoogle Scholar
  37. 37.
    Tech B. HealthWatch Pro. BioVisual Tech, 2000. http://biovisualtech.com/healthwatch/ (accessed June 21, 2008).
  38. 38.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 2004;24:e149–161.PubMedCrossRefGoogle Scholar
  39. 39.
    Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115:e290–296.PubMedCrossRefGoogle Scholar
  40. 40.
    Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003;157:821–827.PubMedCrossRefGoogle Scholar
  41. 41.
    Pietrobelli A, Faith MS, Allison DB, Gallagher D, Chiumello G, Heymsfield SB. Body mass index as a measure of adiposity among children and adolescents: a validation study. J Pediatr 1998;132:204–210.PubMedCrossRefGoogle Scholar
  42. 42.
    Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM. Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child 1991;145:259–263.PubMedGoogle Scholar
  43. 43.
    Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500–503.PubMedCrossRefGoogle Scholar
  44. 44.
    Deskins S, Harris CV, Bradlyn AS, Cottrell L, Coffman JW, Olexa J, et al. Preventive care in Appalachia: use of the theory of planned behavior to identify barriers to participation in cholesterol screenings among West Virginians. J Rural Health 2006;22:367–374.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Christa L. Ice
    • 1
  • Emily Murphy
    • 1
  • Valerie Evans Minor
    • 2
  • William A. Neal
    • 1
  1. 1.Department of PediatricsWest Virginia UniversityMorgantownUSA
  2. 2.Department of NursingAlderson-Broaddus CollegeMorgantownUSA

Personalised recommendations